81% of Clinical Trial Volunteers Suffer Reactions to CanSino Biologics’ COVID-19 Vaccine – Collective Evolution

CanSino’s Ad5-n-CoV vaccine uses a chimpanzee adenovirus vector that uses the HEK293 cell lines derived from the tissue of an aborted fetus. The HEK293 human fetal cell line, which was designed, developed and is licensed by Canada’s National Research Council (NRC), is also being used to produce the AZD1222 COVID-19 vaccine developed by the University of Oxford’s Jenner Institute.

Why It Matters: COVID-19 vaccines are being rushed to market, and vaccines that are rushed to market never have a good safety record. Given that even Moderna’s COVID vaccine also showed negative reactions, people should think twice about opting in for the vaccine, especially given COVID-19 is continuing to prove it is not as dangerous or life-threatening as mainstream media has been making it sound.

While the introduction of a vaccine will mean huge dollars for pharmaceutical companies, like the seasonal flu vaccine, it seems unnecessary and potentially can cause more harm than the good it could do. Vaccines for illnesses similar to COVID-19 often don’t protect high percentages of takers from the illness it attempts to prevent.

81% of Clinical Trial Volunteers Suffer Reactions to CanSino Biologics’ COVID-19 Vaccine – Collective Evolution